TrialHead & neck2011
Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer.
Gregory T Wolf et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this paperpooled ittrialcites it